Sodium 1,4-dihydroxy-9,10-dioxo-3-(4-sulfonatophenoxy)-9,10-dihydroanthracene-2-sulfonate

Catalog No. :
ACVPTQ995
CAS No. :
94094-64-1
Molecular Formula :
C20H10Na2O11S2
Molecular Weight :
536.40

IUPAC Name:sodium 1,4-dihydroxy-9,10-dioxo-3-(4-sulfonatophenoxy)-9,10-dihydroanthracene-2-sulfonate

Sodium 1,4-dihydroxy-9,10-dioxo-3-(4-sulfonatophenoxy)-9,10-dihydroanthracene-2-sulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 1,4-dihydroxy-9,10-dioxo-3-(4-sulfonatophenoxy)-9,10-dihydroanthracene-2-sulfonate
IUPAC Namesodium 1,4-dihydroxy-9,10-dioxo-3-(4-sulfonatophenoxy)-9,10-dihydroanthracene-2-sulfonate
Molecular FormulaC20H10Na2O11S2
Molecular Weight536.40
SMILESO=S(C(C(O)=C1C2=O)=C(OC3=CC=C(S(=O)([O-])=O)C=C3)C(O)=C1C(C4=C2C=CC=C4)=O)([O-])=O.[Na+].[Na+]
InChI KeyJBQQJBHUQSTJND-UHFFFAOYSA-L
Synonymdisodium 9,10-dihydro-1,4-dihydroxy-9,10-dioxo-3-(4-sulphonatophenoxy)anthracene-2-sulphonate;9,10-Dihydro-1,4-dihydroxy-9,10-dioxo-3-(4-sulfophenoxy)-2-anthracenesulfonic acid disodium salt
CAS No.94094-64-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVPTQ995 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGIPY460 route compound structure diagram
    ACGIPY460825-90-1 In Stock
  4. Then
  5. ACVPTQ995 route product structure diagram
    ACVPTQ99594094-64-1
Inquiry

2. ACVPTQ995 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVPTQ995 route product structure diagram
    ACVPTQ99594094-64-1
Inquiry

Comments (0)